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Undifferentiated carcinoma of the parotid gland contains clonal Epstein-Barr virus episomes without ladder
arrays of restriction enzyme fragments representing virion DNA. Analysis of Epstein-Barr virus transcription
in situ in parotid carcinoma specimens revealed that the EBER RNAs, latent membrane protein mRNA, and
the BamHI-A rightward reading frame, BARFO, are expressed in the malignant epithelial cells.
The close association of Epstein-Barr virus (EBV) infec-
tion with certain malignancies is well documented. EBV
genomes and virally encoded antigens are consistently de-
tected in the endemic African form of Burkitt's lymphoma,
lymphoproliferative syndromes in immunocompromised
hosts, and in an epithelial malignancy, nasopharyngeal car-
cinoma (NPC) (8, 18, 23, 25). In these proliferations, all of
the malignant cells are infected with EBV and express
specific EBV genes. In nonpermissively or latently infected
lymphoid cell lines, six distinct nuclear antigens (EBNA),
two small nonpolyadenylated RNAs (EBERs), latent mem-
brane protein (LMP), and two additional potential mem-
brane proteins (LMP2A and 2B) are expressed (1, 19). In
contrast, in NPC tissue, of the six EBNA proteins, only
EBNA 1 is detected (9, 34); however, transcription of the
DNA sequences representing LMP1, LMP2, the EBERS,
and the BamHI A fragment is consistently detected (11, 12,
26, 32).
EBV infection has also been detected in other epithelial
malignancies, including carcinoma of the palatine tonsil, the
supraglottic larynx, and the salivary gland (3, 4, 16, 20, 28).
It has also been shown that EBV replicates in oropharyngeal
epithelial cells and in the ductal epithelium of the salivary
gland, with detection of virus in the saliva after infectious
mononucleosis (13, 22, 30, 31, 33). Therefore, it is important
to determine whether the detection of EBV DNA in a
particular tissue represents transient reactivated viral repli-
cation or a latent infection that might result in EBV-induced
cellular proliferation.
In this study, EBV DNA structure and expression were
characterized in specimens of undifferentiated carcinoma of
the parotid gland (PC), obtained from American Eskimos
(20). This is a rare malignancy, reported predominantly in
Eskimos, who are also at high risk for developing NPC (16,
20, 28).
Identification of the EBV termini. Analysis of the terminal
restriction enzyme fragments ofEBV distinguishes the linear
virion form of EBV from the episomal EBV DNA detected
in latently infected cells (Fig. 1). The fused terminal restric-
tion enzyme fragments of the episomal form are larger and
will hybridize to probes representing unique DNA from both
ends of the viral genome, whereas linear DNA produces
ladder arrays of restriction enzyme fragments which indicate
the presence of virion DNA (5, 7, 18, 24, 29). In the few
integration events which have been described, integration
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occurred at the termini or within the BamHI C fragment at
the left end of the genome (17, 21). After digestion with
restriction enzymes, the left and right EBV-cell fusion
fragments can be distinguished (Fig. 1).
The clinical presentation and detection of EBV DNA in
six PC specimens and the absence of EBV DNA in other
pathologies of the salivary gland have been described previ-
ously (20). Specimen P57 represents patient 4, and T33
represents patient 5 (20). To characterize EBV DNA in PCs
and to determine whether the EBV DNA represented episo-
mal DNA, Southern blots were prepared with dilutions of
Raji DNA, representing approximately 50 and 5 copies of
episomal DNA, and two samples of PC DNA. Hybridization
with both EcoRI-I and XhoI-a identified a 15-kb fragment in
P57 and a 13-kb fragment in T33, two specimens of PC, but
not in normal parotid tissue from the same glands, N33 (Fig.
2; data not shown for P57) (2, 7, 20). A small fragment was
also detected by the XhoI-a probe but not the EcoRI-I probe
in T33 and in a squamous cell carcinoma of the maxillary
sinus, OTH31. EBV was not detected in pleomorphic ade-
noma of the submaxillary gland, in a submandibular mass
representing sialadenitis, or in a submandibular adenoid
cystic carcinoma (20).
To determine whether these additional fragments repre-
sented potential integration events, T33 and OTH31 were
hybridized to the BamHI C, W, and F fragments (adjacent to
EcoRI-I) and to BamHI-A (adjacent to XhoI-a). These
probes detected the standard BamHI C, W, F, and A
fragments in T33, presumably representing the episomal
DNA in this specimen, but did not identify potential viral-
cellular junction fragments. The probes did not hybridize to
OTH31 (data not shown). The negative hybridization with
the four probes in OTH31 suggests that the detected DNA
fragment is an anomalous fragment which cross-hybridizes
to the XhoI-a probe.
The identification of EBV DNA in malignant but not
adjacent normal tissue and the absence of terminal fragments
representing linear DNA indicate that the presence of EBV
genomes in PCs does not reflect transient reactivation of
EBV DNA replication in parotid tissue. In addition, the
detection of clonal episomal DNA suggests that carcinoma
of the salivary gland is a latent EBV infection with clonal
cellular proliferation.
Analysis of EBV expression. Analyses of viral transcription
in NPC specimens obtained at biopsy or passaged in nude
mice have determined that the EBER RNAs, LMP mRNA,
and transcription from the BamHI A fragment are expressed
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FIG. 1. Structure of the viral termini: schematic diagram of the three forms of EBV DNA. The terminal fragments produced by digestion
with a restriction enzyme, indicated with an arrow, can be identified with probes, which are underlined, representing unique DNA adjacent
to the termini. Representative Southern blots indicative of the three forms are diagrammed.
in all cells in NPC specimens and in NPC passaged in nude
mice (6, 10, 11, 14, 26).
PC represents another example of a latently infected
malignant epithelial tissue. To determine whether the same
RNAs which are transcribed in NPCs are also expressed in
PCs, 35S-labelled, single-stranded RNA probes were synthe-
sized from the sequences which encode EBER1 and LMP
and from BamHI-A cDNA in sense and antisense orientation
(10-12, 15). The antisense probes, homologous to the EBV
mRNAs, were hybridized to pieces of the T33 specimen in
comparison with hybridization to pieces of the C15 NPC
tumor, an NPC tumor established in nude mice (6, 11). The
probes in sense orientation were used in control hybridiza-
tions to the C15 tumor as shown previously (10, 11).
A
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Hybridization with the RNA probes homologous to
EBER1, LMP1, and BamHI-A were positive in all cells in
the C15 tumor and in the epithelial cells in the PC (Fig. 3).
35S has a strong radioactive emission which results in a
positive signal for some distance and detection of a few
grains on infiltrating lymphocytes. However, areas of pre-
dominant lymphoid infiltration, represented by the dark-
staining nuclei, were largely negative (Fig. 3A). These data
revealed that the epithelial cells were infected with EBV and
that the detection of EBV was not due to infiltrating lym-
phocytes.
These data document in detail a second epithelial malig-
nancy linked to EBV infection. The absence of linear forms
of EBV, the absence of EBV in adjacent normal tissue, and
B
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FIG. 2. Identification of the terminal EBV fragments in PC specimens. Duplicate Southern blots were prepared with total DNA extracted
from tissue specimens compared with the latently infected lymphoid line, Raji, which contains approximately 50 copies of episomal DNA
(R50) and a dilution representing 5 copies of EBV DNA (R5). Specimens include P41 and P49, pleomorphic adenoma of the parotid gland;
OTH385, a submandibular mass representing sialadenitis; P54, normal parotid gland; P57, undifferentiated PC; N33, normal parotid gland
from patient 33; T33, undifferentiated PC from patient 33; OTH31, squamous cell carcinoma of the maxillary sinus; and OTH394,
submandibular mass representing adenoid cystic carcinoma. The blots were hybridized to EcoRI-I, representing the left end of the genome
(A), and to the XhoI a fragment, representing the right end of the genome (B), as described previously (24). The molecular sizes (in kilobases)
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FIG. 3. Analysis of EBV transcription in situ. Pieces of PC (A, C, and E) and the C15 NPC tumor (B, D, and F) were hybridized to
"S-labelled RNA probes synthesized in antisense orientation to EBER 1 (A and B), LMP (C and D), and BamHI-A cDNA (C and F) as
described previously (10-12). The tissues were treated with RNase, fixed, embedded, sectioned, and exposed to emulsion for 1 week. All










the detection of clonal termini indicate a specific association
of EBV with this carcinoma. The data reveal that PC
represents a tissue which is latently infected with a clonal
population of EBV episomes, analogous to NPC. The clon-
ality of EBV episomes suggests, by extension, cellular
clonality.
In addition to the histopathologic similarity and identical
state of EBV infection, these studies show that the same
viral sequences are transcribed in both NPC and PC speci-
mens. The EBV transforming gene product, LMP, was
expressed in both diseases in all cells. LMP is not believed to
be expressed in Burkitt's lymphoma tissue in vivo (27). The
expression of LMP in two epithelial tumors infected with
EBV suggests that LMP may be required for epithelial
growth.
In addition, both epithelial infections are characterized by
rightward transcription from the BamHI A fragment. This
fragment is not transcribed in latently infected lymphoid
cells but is transcribed in all cells in NPC tissue. The
detection of transcription from BamHI-A in two epithelial
malignancies suggests that this gene may also be essential to
latent EBV infection in epithelial cells or epithelial cell
proliferation. The similarity in viral expression suggests that
EBV makes a similar contribution to the etiology of undif-
ferentiated PC and NPC.
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